Navigating the Intersection of Foreign Investment Review and Merger Review
12 PM EST
Getting cross-border deals done in a complex regulatory environment where antitrust merger review frequently intersects with foreign investment and sectoral review has become more challenging. High profile deals such as GE/Alstom, Pfizer/AstraZeneca, ADM/GrainCorp and Ralls/Sany illustrate the relevance of this issue. This program features a former CFIUS official, who will provide an inside perspective into the CFIUS process, as well as speakers from the private sector with significant foreign investment review experience in the US, UK and EU. Panelists will also provide practical tips for efficiently achieving foreign investment review approvals.
*Michael Keeley, Axinn Veltrop & Harkrider LLP
*Timothy R.W. Cowen, Sidley Austin LLP
*Anne W. Salladin, Stroock & Stroock & Lavan LLP
*William R. Vigdor, Vinson & Elkins LLP
FREE: Antitrust Section Members, Government, Nonprofit Emmployees and Students.
$25.00: Other Non-members.
Learn about Section membership or call 800-285-2221 to join with source code: RAT14IP25. Instructions for accessing the live program will be provided in a confirmation email. For this and all upcoming events visit: http://AmBar.org/ATEvents.
The ABA is not seeking CLE credit for this program.
Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.